HIV AIDS

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.

The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.

The underpinnings of the global HIV and STI epidemics are inextricable. A new report looks at combined solutions. We offer highlights.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

A first-of-its-kind study found that among cirrhosis patients with and without HIV-coinfection, liver function improved >50% in each cohort.

What are the top 5 HIV/AIDS apps that both physicians and patients can use? Scroll through our new slideshow to find out. 

Further hope for prevention of transmission as the search for a cure continues.

Research supports liver and kidney transplantation in patients with HIV infection, but referral rates are low.

Test your knowledge of the latest National Comprehensive Cancer Network guidelines for cancer in patients with HIV infection.